Feng Chi Biotech Corp. (TPEX:6744)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
16.70
-0.10 (-0.60%)
At close: Apr 24, 2026

Feng Chi Biotech Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
177.36171.1180.58193.46182.57
Revenue Growth (YoY)
3.66%-5.25%-6.66%5.96%2.05%
Cost of Revenue
98.293.9599.86110.0296.46
Gross Profit
79.1677.1580.7283.4486.11
Selling, General & Admin
51.8146.4343.4644.2945.48
Research & Development
13.514.613.112.0914.19
Operating Expenses
65.3161.0356.5656.3859.67
Operating Income
13.8516.1224.1627.0726.44
Interest Expense
-0.18-0.25-0.33-0.06-0.1
Interest & Investment Income
33.243.091.881.38
Currency Exchange Gain (Loss)
0.040.680.341.50.01
Other Non Operating Income (Expenses)
0.230.540.030.030.13
EBT Excluding Unusual Items
16.9320.3327.330.4227.86
Gain (Loss) on Sale of Assets
----0.2
Pretax Income
16.9320.3327.330.4228.06
Income Tax Expense
2.463.744.515.814.92
Net Income
14.4716.5922.7924.6123.14
Net Income to Common
14.4716.5922.7924.6123.14
Net Income Growth
-12.78%-27.19%-7.40%6.39%-8.89%
Shares Outstanding (Basic)
1515151515
Shares Outstanding (Diluted)
1515151515
Shares Change (YoY)
-0.08%0.02%-0.07%0.08%0.01%
EPS (Basic)
0.941.081.481.601.50
EPS (Diluted)
0.941.071.471.601.50
EPS Growth
-12.16%-27.21%-8.03%6.55%-8.54%
Free Cash Flow
-9.7910.4614.0228.431.83
Free Cash Flow Per Share
-0.630.680.911.842.06
Dividend Per Share
-0.9501.0501.3501.250
Dividend Growth
--9.52%-22.22%8.00%8.70%
Gross Margin
44.63%45.09%44.70%43.13%47.16%
Operating Margin
7.81%9.42%13.38%13.99%14.48%
Profit Margin
8.16%9.70%12.62%12.72%12.67%
Free Cash Flow Margin
-5.52%6.11%7.76%14.68%17.43%
EBITDA
23.2522.6228.6630.6732.53
EBITDA Margin
13.11%13.22%15.87%15.85%17.82%
D&A For EBITDA
9.416.54.53.66.09
EBIT
13.8516.1224.1627.0726.44
EBIT Margin
7.81%9.42%13.38%13.99%14.48%
Effective Tax Rate
14.52%18.39%16.51%19.08%17.55%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.